Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 1999 Mar 6;318(7184):666-7; author reply 668.
doi: 10.1136/bmj.318.7184.666a.

Treating type 2 diabetes. Study was conducted in exemplary fashion

K M Narayan, G L Beckles, E W Gregg, D F Williamson, J Saaddine, M M Engelgau, F Vinicor
Comment

Treating type 2 diabetes. Study was conducted in exemplary fashion

K M Narayan et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–853. - PubMed
    1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713. . (12 September.) - PMC - PubMed
    1. Nathan DM. Some answers, more controversy, from UKPDS. [Editorial.] Lancet. 1998;352:832–833. - PubMed
    1. Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, et al. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128:176–185. - PubMed
    1. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the diabetes control and complications trial. N Engl J Med. 1993;329:978–986. - PubMed

Substances